Biotech stocks are about to rally (this one can double your money)

Biotech stocks rocketed 500% last time we saw these conditions... You are receiving this as part of your free subscription to Money Morning Stock VQScore™. To remove your email from this list, unsubscribe here.

Click here to access your top-25 ranked stocks! April 20, 2019 Buy Our Top-Scoring Biotech Stocks for Windfall Profits in 2019 Dear VQScore Member, Top-Ranked Stocks on the Move Camping World Holdings Inc. (NASDAQ: CWH), Ranked No. 25 CWH just earned a position in the Money Morning Stock VQScore™ Top 25 for the first time. This is a cyclical stock that has historically performed better in the spring and summer months due to the seasonality of its businesses. Our price target indicates a 57% increase by the end of summer. You can find our full rankings, including our No. 1 stock, here. Time to Collect Your 72% Gain Since VQScore™ identified Coca-Cola Consolidated Inc. (NASDAQ: COKE) as a top pick on Oct. 30 for us, the stock is up 72%. Because our new $300 price target is just about fulfilled and the stock no longer holds our highest score, we suggest taking your profits and buying another Top-25 VQ stock instead. During the dot-com era between 1998 and early 2000, one sector significantly outperformed the rest. Right now, my team is seeing many similarities in the market today, but with one big exception... The rise in stocks will be calmer and extend over a longer period. That means there won't be a quick-forming "bubble" that bursts abruptly in your face this time. When most people reminisce on the dot-com mania, they think about how the Nasdaq grew roughly 200%. But the Nasdaq biotechnology sector skyrocketed over 500%. See, that's exactly why I love investing in biotech stocks. You can't find these types of quick gains anywhere else... And our proprietary Money Morning Stock VQScore™ recently system identified three profitable biotech companies with serious momentum building for their shares. This system weeds out the thousands of unprofitable biotech stocks with long-shot drugs that have lower odds of earning FDA approval. So you don't have to worry about any bubble popping when it comes to VQScore stocks. Each of our three picks has solid financials, and one could easily double your money if you buy today... Sincerely, Kyle Anderson Head of VQ Research Pad Your Portfolio with These 3 Income Investing Strategies Last month, the yield curve inverted for the first time since 2007. Since an inversion is one of Wall Street's favorite bellwethers for a recession, investors are starting to prepare for a downturn. And income investing is a powerful tool to make sure you stay in the green during a market downturn. Here are our top three income investing tips to protect your portfolio... Full Story The 3 Best REITs to Buy This Month What's the secret of the world's wealthiest investors? REITs. These alternative investments can outperform in any market. And best of all, they provide distinct tax advantages that you rarely find anywhere else. Here are the three best REITs to buy now... Full Story Unsubscribe from Money Morning Stock VQScore™ Manage Your Email Preferences You are receiving this e-mail at its028@gmail.com as a part of your free subscription to the Money Morning Stock VQScore™. To read our privacy policy click here. To cancel by mail or for any other subscription issues, write us at: Money Morning Stock VQScore™ | Attn: Member Services | 1125 N. Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 Contact Customer Service Website: https://moneymorning.com © 2019 Money Morning Stock VQScore™ All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any recommendations in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Money Morning Stock VQScore™. 1125 N. Charles Street, Baltimore MD 21201.